| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/17/2012 | US8097408 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
| 01/17/2012 | US8097407 Metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression |
| 01/17/2012 | US8097406 Associations of single nucleotide polymorphisms and haplotype with feed intake and feed efficiency in beef cattle |
| 01/17/2012 | US8097405 Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs |
| 01/17/2012 | US8097404 Composition and method for cell permeabilization comprising N-octyl-β-D-glucopyranoside, sodium polyphosphates, rubidium chloride and/or lithium chloride for detecting living cells on a membrane |
| 01/17/2012 | US8097209 Method and apparatus for detecting substances or analytes from the analysis of one or more samples |
| 01/17/2012 | CA2524928C Assay method and apparatus |
| 01/17/2012 | CA2523040C Localized temperature control for spatial arrays of reaction media |
| 01/17/2012 | CA2518632C Screening assay |
| 01/17/2012 | CA2510719C Biochip |
| 01/17/2012 | CA2465007C Methods and means for producing proteins with predetermined post-translational modifications |
| 01/17/2012 | CA2461917C Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 01/17/2012 | CA2461915C Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon |
| 01/17/2012 | CA2455118C Nanoparticle imaging system and method |
| 01/17/2012 | CA2441958C Il-28 polypeptides and polynucleotids |
| 01/17/2012 | CA2427916C Surface transfection and expression procedure |
| 01/17/2012 | CA2414542C Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells using electric current |
| 01/17/2012 | CA2334847C Method for determining the existence of a biological activity of microorganisms |
| 01/17/2012 | CA2211147C A method of preparing an undifferentiated cell |
| 01/16/2012 | CA2743077A1 Environmental sentinel biomonitoring system |
| 01/12/2012 | WO2012006632A2 Lung cancer biomarkers and uses thereof |
| 01/12/2012 | WO2012006589A2 Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling |
| 01/12/2012 | WO2012006561A2 Influenza virus detection and diagnosis |
| 01/12/2012 | WO2012006556A2 Detection of analytes |
| 01/12/2012 | WO2012006542A2 Method of detecting single nucleotide polymorphisms |
| 01/12/2012 | WO2012006534A2 Methods, compositions and kits for diagnosing and treating alzheimer's disease using mitochondrial co3 gene mutations |
| 01/12/2012 | WO2012006500A2 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | WO2012006476A2 Methods and compositions for quantifying exosomes |
| 01/12/2012 | WO2012006447A2 Gene signatures for cancer prognosis |
| 01/12/2012 | WO2012006439A2 Production of functionalized linear dna cassette and quantum dot/nanoparticle mediated delivery in plants |
| 01/12/2012 | WO2012006421A2 Diagnosis and treatment of breast cancer |
| 01/12/2012 | WO2012006407A2 Detection of target metabolites |
| 01/12/2012 | WO2012006394A2 Hmga2 as a biomarker for diagnosis and prognosis of ovarian cancer |
| 01/12/2012 | WO2012006391A2 Modulators for sirt5 and assays for screening same |
| 01/12/2012 | WO2012006329A2 Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| 01/12/2012 | WO2012006250A1 System for airborne bacterial sample collection and analysis |
| 01/12/2012 | WO2012006187A2 Methods and devices for the selective detection of microorganisms |
| 01/12/2012 | WO2012006116A2 Methods, workflows, kits, apparatuses, and computer program media for nucleic acid sample preparation for nucleic acid sequencing |
| 01/12/2012 | WO2012006088A1 Method and kit for classifying a patient |
| 01/12/2012 | WO2012006084A2 Systems and methods for transfer of liquid samples |
| 01/12/2012 | WO2012006056A2 Ccr6 as a biomarker of alzheimer's disease |
| 01/12/2012 | WO2012005595A2 V3-d genomic region of interest sequencing strategies |
| 01/12/2012 | WO2012005590A1 A plant heat-resistance gene bccdreb2a and use thereof |
| 01/12/2012 | WO2012005572A1 Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
| 01/12/2012 | WO2012005563A1 Uses of biological compounds from toxoplasma sp and related compounds |
| 01/12/2012 | WO2012005393A1 Natural killer cell receptor genotyping method using multiple gene amplification |
| 01/12/2012 | WO2012005383A2 Method for production of tumor cells from normal mammary epithelial cells |
| 01/12/2012 | WO2012005240A1 Bifidobacterium having activity of reducing amount of intestinal putrefacted substance |
| 01/12/2012 | WO2012004759A2 Method |
| 01/12/2012 | WO2012004619A1 Procedure for the specific isolation of total dna content of bacterial germs and a kit for this purpose |
| 01/12/2012 | WO2012004614A1 Detection of drug-resistant influenza virus |
| 01/12/2012 | WO2012004559A1 Methods for screening for compounds expected to be useful in the modulating, for example inhibiting, the activity of kiaa1018/mtmr15/fan1. |
| 01/12/2012 | WO2012004540A1 Method for the detection and direct identification of a microorganism in a biological sample diluted in an enrichment broth |
| 01/12/2012 | WO2012004346A1 Genetically engineered stem cells, method of production and uses thereof |
| 01/12/2012 | WO2012004203A1 Method for nucleic acid sequencing |
| 01/12/2012 | WO2012003955A1 Fluorescent carbapenems |
| 01/12/2012 | WO2012003950A1 Detection of mutations, in particular deletions or insertions |
| 01/12/2012 | WO2012003579A1 Solid gel amplification method and apparatus for genotyping and pathogen detection |
| 01/12/2012 | WO2012003575A1 Proteins related to the suppression of phytophthora infections in members of the solanaceae family |
| 01/12/2012 | WO2011153590A8 Use of interferon epsilon in methods of diagnosis and treatment |
| 01/12/2012 | WO2011146945A3 Alk and ros kinase in cancer |
| 01/12/2012 | WO2011132977A3 Pcr device including two heating blocks |
| 01/12/2012 | WO2011130426A3 Compositions and methods for treatment of melanoma |
| 01/12/2012 | WO2011129710A4 Microarrays |
| 01/12/2012 | WO2011121097A3 Method and device for analysing molecular bonds |
| 01/12/2012 | WO2011116256A3 Multiphase microarrays and uses thereof |
| 01/12/2012 | WO2011113054A3 Crosslinked polynucleotide structure |
| 01/12/2012 | WO2011112908A3 Optical particle characterization system |
| 01/12/2012 | WO2011108854A3 Method for detecting nucleic acids by promoting branched dna complex formation |
| 01/12/2012 | WO2011107482A9 Method of diagnostic of obesity |
| 01/12/2012 | WO2011106541A3 Diagnostic methods involving loss of heterozygosity |
| 01/12/2012 | WO2011106373A3 Arnt isoform 3 as a predictor of aminoflavone responsiveness in cancer cells |
| 01/12/2012 | WO2011106363A3 Metabolic rate indicator for cellular populations |
| 01/12/2012 | WO2011106356A3 Diagnositic methods of tumor suspectibility with single nucleotide polymorphisms inside microrna target sites |
| 01/12/2012 | WO2011105826A3 Method using camp expression measurement to diagnose prostate inflammation, and diagnostic kit |
| 01/12/2012 | WO2011105732A3 Method and kit for detecting egfr mutation by using pna-based real-time pcr clamping |
| 01/12/2012 | WO2011103502A3 Materials and methods for profiling micrornas |
| 01/12/2012 | WO2011103159A3 Assay for detecting closely- related serotypes of human papillomavirus (hpv) |
| 01/12/2012 | WO2011100669A3 Lable-free multiplexing bioassays using fluorescent conjugated polymers and barcoded nanoparticles |
| 01/12/2012 | WO2011086498A3 Two-stage thermal convection apparatus and uses thereof |
| 01/12/2012 | WO2011085263A3 Method to use gene expression to determine likelihood of clinical outcome of renal cancer |
| 01/12/2012 | US20120011623 Microrna polymorphisms conferring enhanced drought tolerance in a plant |
| 01/12/2012 | US20120011614 Dominant Gene Suppression Transgenes and Methods of Using Same |
| 01/12/2012 | US20120011598 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics |
| 01/12/2012 | US20120010821 Nucleic Acid Abundance Ratio Measurement Device, Method, and Program Storage Medium, Determination Method and Nucleic Acid Abundance Ratio Measurement Kit |
| 01/12/2012 | US20120010597 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf) |
| 01/12/2012 | US20120010276 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 01/12/2012 | US20120010275 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 |
| 01/12/2012 | US20120010274 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 01/12/2012 | US20120010270 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 6 (TSSC6) |
| 01/12/2012 | US20120010269 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN SMS3 |
| 01/12/2012 | US20120010268 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN ACHAETE-SCUTE HOMOLOG 2 (HASH2) |
| 01/12/2012 | US20120010266 Tbc1d7 as tumor marker and therapeutic target for cancer |
| 01/12/2012 | US20120010254 Compounds and methods for treatment of influenza |
| 01/12/2012 | US20120010248 Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof |
| 01/12/2012 | US20120010230 Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling |
| 01/12/2012 | US20120010196 Methods of treating neurodegenerative disorders and diseases |
| 01/12/2012 | US20120010177 MicroRNA Modulators and Method for Identifying And Using The Same |
| 01/12/2012 | US20120010138 Novel uses of vegfxxxb |
| 01/12/2012 | US20120010136 Use of cd31 peptides in the treatment of thrombotic and autoimmune disorders |